PolyPid Ltd. (PYPD), a late-stage biopharma company, on Tuesday announced that it has appointed Nurit Tweezer-Zaks as Chief Medical Officer, effective from August 18.
Nurit Tweezer-Zaks has served on the Board of Directors since November 2023 and is expected to step down from the role to take the position of CMO.
Prior to joining the company, Nurit Tweezer-Zaks served as Chief Executive Officer of MediCane Health Inc.
On Monday, PolyPid closed trading, 0.31% higher at $3.2300 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.